PillRx only · Injection · Intramuscular
Nalbuphine Hydrochloride
Nalbuphine Hydrochloride
3 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US7 NDCs
3 active makers
3 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
US acquisition costNADAC · per unit
Average across 1 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$4.322
Latest avg · Mar 18, 2026
+0%
Since Dec 17, 2025
3
Active US suppliers
86%
Top-2 supplier share*
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
48
Rx · 2026 Q1
542
Units dispensed
2
Quarters · since 2025 Q1
Who makes it3 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Somerset Therapeutics, LLC | unknown | 4 | SUPPLYING |
| Henry Schein Inc. | unknown | 2 | SUPPLYING |
| Medical Purchasing Solutions, LLC | unknown | 1 | SUPPLYING |
Regulatory & supply events
No recalls, shortages, or registration changes on record for this drug concept.